Novonesis (Novozymes) A/S (NSIS-B) — Free Cash Flow Generation Index
Novonesis (Novozymes) A/S (NSIS-B) has a Free Cash Flow Generation Index of 0.53x as of March 2026. Free cash flow of Dkr87.98 Million represents 1% of operating cash flow (Dkr167.06 Million). Explore Novonesis (Novozymes) A/S capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Novonesis (Novozymes) A/S Free Cash Flow Generation Index (2002–2025)
Historical FCF Generation Index trend for Novonesis (Novozymes) A/S across 24 annual periods. For the full cash flow conversion analysis, see Novonesis (Novozymes) A/S (NSIS-B) cash flow conversion.
Annual Free Cash Flow Generation for Novonesis (Novozymes) A/S (2002–2025)
Year-by-year Free Cash Flow Generation Index for Novonesis (Novozymes) A/S. Check NSIS-B cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (DKK) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.61x | Dkr750.70 Million | Dkr1.22 Billion | Dkr470.80 Million | ▼ -5.0% |
| 2024 | 0.65x | Dkr660.10 Million | Dkr1.02 Billion | Dkr359.80 Million | ▲ +28.2% |
| 2023 | 0.50x | Dkr2.10 Billion | Dkr4.15 Billion | Dkr2.06 Billion | ▲ +81.2% |
| 2022 | 0.28x | Dkr1.12 Billion | Dkr4.01 Billion | Dkr2.89 Billion | ▼ -59.9% |
| 2021 | 0.69x | Dkr2.82 Billion | Dkr4.06 Billion | Dkr1.24 Billion | ▼ -11.4% |
| 2020 | 0.78x | Dkr3.42 Billion | Dkr4.36 Billion | Dkr940.00 Million | ▲ +7.4% |
| 2019 | 0.73x | Dkr2.33 Billion | Dkr3.20 Billion | Dkr862.00 Million | ▲ +14.5% |
| 2018 | 0.64x | Dkr2.35 Billion | Dkr3.68 Billion | Dkr1.33 Billion | ▲ +4.9% |
| 2017 | 0.61x | Dkr2.47 Billion | Dkr4.06 Billion | Dkr1.59 Billion | ▼ -15.5% |
| 2016 | 0.72x | Dkr2.76 Billion | Dkr3.84 Billion | Dkr1.08 Billion | ▲ +1.4% |
| 2015 | 0.71x | Dkr2.37 Billion | Dkr3.34 Billion | Dkr968.00 Million | ▼ -15.9% |
| 2014 | 0.84x | Dkr3.82 Billion | Dkr4.53 Billion | Dkr703.00 Million | ▲ +19.5% |
| 2013 | 0.71x | Dkr1.84 Billion | Dkr2.60 Billion | Dkr762.00 Million | ▲ +23.7% |
| 2012 | 0.57x | Dkr1.58 Billion | Dkr2.76 Billion | Dkr1.18 Billion | ▲ +11.8% |
| 2011 | 0.51x | Dkr1.39 Billion | Dkr2.71 Billion | Dkr1.32 Billion | ▲ +19.4% |
| 2010 | 0.43x | Dkr995.00 Million | Dkr2.32 Billion | Dkr1.33 Billion | ▼ -2.4% |
| 2009 | 0.44x | Dkr797.00 Million | Dkr1.82 Billion | Dkr1.02 Billion | ▲ +0.9% |
| 2008 | 0.43x | Dkr738.00 Million | Dkr1.70 Billion | Dkr959.00 Million | ▼ -23.2% |
| 2007 | 0.57x | Dkr971.00 Million | Dkr1.71 Billion | Dkr743.00 Million | ▼ -15.5% |
| 2006 | 0.67x | Dkr1.03 Billion | Dkr1.53 Billion | Dkr505.00 Million | ▼ -7.3% |
| 2005 | 0.72x | Dkr960.00 Million | Dkr1.33 Billion | Dkr366.00 Million | ▼ -2.1% |
| 2004 | 0.74x | Dkr952.00 Million | Dkr1.29 Billion | Dkr335.00 Million | ▲ +4.1% |
| 2003 | 0.71x | Dkr976.00 Million | Dkr1.37 Billion | Dkr398.00 Million | ▲ +3.1% |
| 2002 | 0.69x | Dkr814.00 Million | Dkr1.18 Billion | Dkr367.00 Million | — |